ArticleTheranostics2021

The ATP synthase inhibition induces an AMPK-dependent glycolytic switch of mesenchymal stem cells that enhances their immunotherapeutic potential.

Rafael Contreras-Lopez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.